MedPageToday
MedPage Today) — As researchers keep looking for ways to deescalate treatment in HER2-positive breast cancer, a trial from China looked at a chemotherapy-free regimen with endocrine therapy, a CDK4/6 inhibitor, and trastuzumab (Herceptin) and…
Read More
Chemo-Free Regimen Tested in Early HER2-Positive/HR-Positive Breast Cancer
Sharie Block
02:25
MedPage Today) — As researchers keep looking for ways to deescalate treatment in HER2-positive breast cancer, a trial from China looked at a chemotherapy-free regimen with endocrine therapy, a CDK4/6 inhibitor, and trastuzumab (Herceptin) and…
